Abstract:While p73 overexpression has been associated with increased apoptosis in cancer tissues, p73 overexpressing tumors appear to be of high grade malignancy. Why this putative tumor suppressor is overexpressed in cancer cells and what the function of overexpressed p73 is in breast cancers are critical questions to be addressed. By investigating the effect of p53 inactivation on p73 expression, we found that both protein and mRNA levels of TAp73 were increased in MCF-7/p53siRNA cells, MCF-7/p53mt135 cells and HCT-116/p53−/− cells, as compared to wild type control, suggesting that p53 inactivation by various forms upregulates p73. We showed that p53 knockdown induced p73 was mainly regulated at the transcriptional level. However, although p53 has a putative binding site in the TAp73 promoter, deletion of this binding site did not affect p53 knockdown mediated activation of TAp73 promoter. Chromatin immuno-precipitation (ChIP) data demonstrated that loss of p53 results in enhanced occupancy of E2F-1 in the TAp73 promoter. The responsive sequence of p53 inactivation mediated p73 upregulation was mapped to the proximal promoter region of the TAp73 gene. To test the role of E2F-1 in p53 inactivation mediated regulation of p73 transcription, we found that p53 knockdown enhanced E2F-1 dependent p73 transcription, and mutations in E2F-1 binding sites in the TAp73 promoter abrogated p53 knockdown mediated activation of TAp73 promoter. Moreover, we demonstrated that p21 is a mediator of p53-E2F crosstalk in the regulation of p73 transcription. We concluded that p53 knockdown/inactivation may upregulate TAp73 expression through E2F-1 mediated transcriptional regulation. p53 inactivation mediated upregulation of p73 suggests an intrinsic rescuing mechanism in response to p53 mutation/inactivation. These findings support further analysis of the correlation between p53 status and p73 expression and its prognostic/predictive significance in human cancers.

Role of p73 in regulating human caspase-1 gene transcription induced by interferon-{gamma} and cisplatin

Abstract 882: A novel p73 C-terminal isoform, p73α1, regulates inflammation and tumor suppression via the Notch1 pathway

Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity

Interferon Regulatory Factor 1 Transactivates Expression of Human DNA Polymerase Η in Response to Carcinogen N-Methyl-N′-nitro-N-nitrosoguanidine

P73 Coordinates with Δ133p53 to Promote DNA Double-Strand Break Repair

P53 Inactivation Upregulates P73 Expression Through E2F-1 Mediated Transcription.

Tumor suppressor p73 transcriptionally regulates to impede its priming of extrinsic apoptosis while a “switcher compound” degrades c-FLIP protein

P53-Dependent Caspase-2 Activation in Mitochondrial Release of Apoptosis-inducing Factor and Its Role in Renal Tubular Epithelial Cell Injury

p73 in Cancer

Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy

Dual Role of p73 in Cancer Microenvironment and DNA Damage Response

Regulation of PUMA- α by p53 in cisplatin-induced renal cell apoptosis

Abstract LB-75: Glucocorticoid Receptor Activation Inhibits P53-Induced Apoptosis of MCF10A Myc Cells Via Induction of Protein Kinase C Epsilon

p73 activation is involved in regulation of Ara-C-induced apoptosis in human lung adenocarcinoma cells

Glucocorticoid Receptor Activation Inhibits P53-Induced Apoptosis of MCF10Amyc Cells Via Induction of Protein Kinase Cϵ

Inhibition Of Tumor Suppressor P73 By Nerve Growth Factor Receptor Via Chaperone-Mediated Autophagy

Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2

Piasy Interacts With P73 Alpha And Regulates Cell Cycle In Hek293 Cells

Caspase-11 Promotes Cisplatin-Induced Renal Tubular Apoptosis through a Caspase-3-dependent Pathway.

Transcriptional role of p53 in interferon-mediated antiviral immunity

The ubiquitin-protein ligase Itch regulates p73 stability.